CLINICAL_TRIALS
trial_result
· 2017-04-14
Clinical Trial Update: N-methyl-D-aspartate Antagonist (Ketamine) Augmentation of Electroconvulsive Treatment for Severe Major Depression [Phase 4]
Summary
A Phase 4 trial evaluated whether ketamine augmentation of electroconvulsive therapy improves outcomes in severe major depressive disorder. The study was termin…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Major Depressive Disorder | Phase 4 | Status: TERMINATED | Results posted: 2017-04-14